[HTML][HTML] Cannabinoids as therapeutic agents in cancer: current status and future implications
B Chakravarti, J Ravi, RK Ganju - Oncotarget, 2014 - ncbi.nlm.nih.gov
The pharmacological importance of cannabinoids has been in study for several years.
Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant,(b) …
Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant,(b) …
[HTML][HTML] Design and biological evaluation of delivery systems containing bisphosphonates
Bisphosphonates have found application in the treatment of reoccurrence of bone diseases,
breast cancer, etc. They have also been found to exhibit antimicrobial, anticancer and …
breast cancer, etc. They have also been found to exhibit antimicrobial, anticancer and …
A Review on Re-Packaging of Bisphosphonates Using Biomaterials
The need for bone repair and insight into new regeneration therapies as well as
improvement of existing regeneration routes is constantly increasing as a direct …
improvement of existing regeneration routes is constantly increasing as a direct …
Role of ATP-sensitive potassium channels in modulating nociception in rat model of bone cancer pain
H Xia, D Zhang, S Yang, Y Wang, L Xu, J Wu, J Ren… - Brain research, 2014 - Elsevier
Bone cancer pain is a major clinical problem and remains difficult to treat. ATP-sensitive
potassium (K ATP) channels may be involved in regulating nociceptive transmission at the …
potassium (K ATP) channels may be involved in regulating nociceptive transmission at the …
Pathogenesis and bisphosphonate treatment of skeletal events and bone pain in metastatic cancer: focus on ibandronate
HB Sittig - Oncology Research and Treatment, 2012 - karger.com
Bone metastases are the most common cause of pain in patients with advanced cancer, and
are associated with progressive skeletal destruction, spinal problems, and hypercalcaemia …
are associated with progressive skeletal destruction, spinal problems, and hypercalcaemia …
[PDF][PDF] Severe Refractory Hypocalcemia Caused by Denosumab
S Dadana, S Gundepalli, A Kondapalli - Cureus, 2023 - cureus.com
Denosumab is a fully human monoclonal antibody that binds to the receptor activator of
nuclear factor kappa-Β ligand, an essential cytokine factor in bone resorption, which reduces …
nuclear factor kappa-Β ligand, an essential cytokine factor in bone resorption, which reduces …
Adjuvant Therapies in Metastatic Bone Disease
R Yechieli, S Bialick, C Seldon, E Jonczak - Operative techniques in …, 2021 - Elsevier
Bone is a common site of metastatic disease in both solid tumor and hematologic
malignancies. Skeletal involvement of cancer and the complications from these metastases …
malignancies. Skeletal involvement of cancer and the complications from these metastases …
Severe Refractory Hypocalcemia Caused by Denosumab
D Sriharsha, G Sai, K Anusha - Cureus, 2023 - search.proquest.com
Denosumab is a fully human monoclonal antibody that binds to the receptor activator of
nuclear factor kappa-Β ligand, an essential cytokine factor in bone resorption, which reduces …
nuclear factor kappa-Β ligand, an essential cytokine factor in bone resorption, which reduces …
Management of Metastatic Bone Pain in a Patient with Advanced Breast Cancer: The Advanced Practice Nurse's Perspective.
YU Xia - Singapore Nursing Journal, 2017 - search.ebscohost.com
Metastatic bone pain can be very severe and disabling. Effective management requires a
multi-modal multidisciplinary approach. Rennie (pseudonym), a 58-year-old lady was …
multi-modal multidisciplinary approach. Rennie (pseudonym), a 58-year-old lady was …
Palliative Treatments for the Sacrum
A wide array of tumors can occur in the sacrum. Benign tumors include giant cell tumors
(60%), aneurysmal bone cysts (4%), and osteoblastomas [1]. Malignant tumors of the …
(60%), aneurysmal bone cysts (4%), and osteoblastomas [1]. Malignant tumors of the …